UroGen Pharma Ltd. (URGN) › Gross ProfitUroGen Pharma Ltd. (URGN) — Gross ProfitAnnual figures by period end, from SEC filings.2016-12-31: $17.50M2017-12-31: $7.56M2018-12-31: -$675.0K2019-12-31: $18.0K2020-12-31: $10.79M2021-12-31: $42.88M2022-12-31: $56.70M2023-12-31: $73.35M2024-12-31: $81.52M2025-12-31: $97.34M$97.34M2016-12-31Gross Profit (USD)2025-12-31Period endedGross ProfitChange YoYSource filing2025-12-31$97.34M+19.4%2026-03-02From 2025-01-012024-12-31$81.52M+11.1%2026-03-02From 2024-01-012023-12-31$73.35M+29.4%2025-03-10From 2023-01-012022-12-31$56.70M+32.2%2024-03-14From 2022-01-012021-12-31$42.88M+297.5%2023-03-24From 2021-01-012020-12-31$10.79M+59844.4%2022-03-21From 2020-01-012019-12-31$18.0K—2021-03-18From 2019-01-012018-12-31-$675.0K-108.9%2020-03-02From 2018-01-012017-12-31$7.56M-56.8%2020-03-02From 2017-01-012016-12-31$17.50M—2019-02-28From 2016-01-01Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)